Search results
Q1 2024 AbbVie Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 20 hours agoTotal net revenues were $12.3 billion, approximately $400 million ahead of our expectations. This overachievement was driven by our ex-Humira growth platform, which delivered revenue growth ...
5 stocks to watch on Friday: XOM, CVX, ABBV and more
Seeking Alpha· 1 day agoExxon Mobil (XOM), Chevron (CVX), AbbVie (ABBV), Skechers (SKX) and Atlassian (TEAM) are the stocks to watch on Friday.
AbbVie Raises Earnings Guidance Even as Humira Sales Continue to Drop
Barrons.com· 1 day agoAbbVie raised its full-year earnings outlook despite continuing sales declines for autoimmune drug...
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 1 day agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
CPAP Stock Rockets As Quarterly Report Wipes Out Weight-Loss Woes
Investor's Business Daily· 1 day agoResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 4 days agoGet a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 3 days agoThe Zacks Consensus Estimate is pegged at $2.26 per share. AbbVie’s top line is expected to have...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 3 days agoNewer immunology medicines, Skyrizi and Rinvoq, are performing extremely well, bolstered by approval...
AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth
Market Watch· 2 days agoAbbVie Inc. on Friday reported first-quarter results that beat expectations, even as sales of...
Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s...
Fortune via Yahoo Finance· 4 days ago“We believe that growth from ABBV’s ex-Humira business (primarily Skyrizi, Rinvoq, and aesthetics)...
